New drug aims to slash stubborn fat in the blood
Disease control
Ongoing
This study tests an experimental drug called MAR001 in 216 adults with high triglycerides and remnant cholesterol, types of fat in the blood linked to heart disease. Participants receive either MAR001 or a placebo to see if the drug lowers these fats more than placebo. The goal i…
Phase: PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:38 UTC